Vectors Research Management, LLC Bristol Myers Squibb CO Transaction History

Vectors Research Management, LLC

$291 Million
Q2 2025

A detailed history of Vectors Research Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Vectors Research Management, LLC holds 13,000 shares of BMY stock, worth $605,150. This represents 0.21% of its overall portfolio holdings.

Number of Shares

13,000

Previous 13,000 -0.0%

Holding current value

$605,150

Previous $792,000 24.12%

% of portfolio

0.21%

Previous 0.28%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 23, 2025	SELL	$53.9 - $63.11 $13,313 - $15,588	-247 Reduced 1.86%	13,000 $792,000
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $8,780 - $9,955	-183 Reduced 1.36%	13,247 $718,000
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $2,230 - $2,661	-46 Reduced 0.34%	13,430 $696,000
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $17,367 - $19,419	-300 Reduced 2.18%	13,476 $782,000
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $15,608 - $17,331	-245 Reduced 1.75%	13,776 $881,000
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $5,848 - $6,633	-89 Reduced 0.63%	14,021 $972,000
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $3,150 - $3,730	46 Added 0.33%	14,110 $1.02 Million
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $152 - $90,363	-1,176 Reduced 7.72%	14,064 $1 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $77,485 - $85,338	1,067 Added 7.53%	15,240 $1.17 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $4,488 - $5,381	-73 Reduced 0.51%	14,173 $1.04 Million
Q2 2021 Aug 09, 2021	BUY	$61.91 - $67.42 $4,519 - $4,921	73 Added 0.52%	14,246 $951,000
Q1 2021 May 18, 2021	BUY	$59.34 - $66.74 $5,934 - $6,673	100 Added 0.71%	14,173 $895,000
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $52,370 - $59,345	907 Added 6.89%	14,073 $873,000
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $40,775 - $45,184	-710 Reduced 5.12%	13,166 $788,000
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $22,476 - $26,276	410 Added 3.04%	13,876 $816,000
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $4,640 - $6,743	-100 Reduced 0.74%	13,466 $751,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $22,144 - $28,885	450 Added 3.43%	13,566 $871,000
Q3 2019 Nov 15, 2019	SELL	$42.77 - $50.71 $32,505 - $38,539	-760 Reduced 5.48%	13,116 $665,000
Q2 2019 Aug 12, 2019	SELL	$44.62 - $49.34 $669 - $740	-15 Reduced 0.11%	13,876 $629,000
Q1 2019 Jul 15, 2019	BUY	$45.12 - $53.8 $591,162 - $704,887	13,102 Added 1660.58%	13,891 $663,000
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $639,779 - $829,640	-13,121 Reduced 94.33%	789 $41,000
Q3 2018 Nov 15, 2018	BUY	$55.19 - $62.25 $767,692 - $865,897	13,910 New	13,910 $768,000

Others Institutions Holding BMY

# of Institutions

2,662

Shares Held

1.63B

Call Options Held

24.8M

Put Options Held

23.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vectors Research Management, LLC with notifications on news.

Account

Vectors Research Management, LLC Bristol Myers Squibb CO Transaction History